Daihan Pharmaceutical (Korea) Analysis
| 023910 Stock | KRW 27,400 150.00 0.55% |
Daihan Pharmaceutical CoLtd is fairly valued with Real Value of 26550.0 and Hype Value of 27400.0. The main objective of Daihan Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Daihan Pharmaceutical CoLtd is worth, separate from its market price. There are two main types of Daihan Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Daihan Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Daihan Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Daihan Pharmaceutical stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Daihan Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Daihan |
Daihan Stock Analysis Notes
About 35.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Daihan Pharmaceutical had 10:1 split on the 29th of April 2002. ,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Daihan Pharmaceutical CoLtd please contact Yun Lee at 82 2 2678 3911 or go to https://www.daihan.com.Daihan Pharmaceutical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Daihan Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Daihan Pharmaceutical CoLtd or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| About 35.0% of the company shares are owned by insiders or employees |
Daihan Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 182.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Daihan Pharmaceutical's market, we take the total number of its shares issued and multiply it by Daihan Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Daihan Profitablity
Daihan Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Daihan Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Daihan Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Daihan Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Daihan Pharmaceutical's profitability requires more research than a typical breakdown of Daihan Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Technical Drivers
As of the 1st of December, Daihan Pharmaceutical shows the Coefficient Of Variation of 2075.91, mean deviation of 0.6376, and Downside Deviation of 0.9501. Daihan Pharmaceutical technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Daihan Pharmaceutical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Daihan Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Daihan Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Daihan Pharmaceutical Outstanding Bonds
Daihan Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Daihan Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Daihan bonds can be classified according to their maturity, which is the date when Daihan Pharmaceutical CoLtd has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Daihan Pharmaceutical Predictive Daily Indicators
Daihan Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Daihan Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0291 | |||
| Daily Balance Of Power | 0.1875 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 27050.0 | |||
| Day Typical Price | 27166.67 | |||
| Market Facilitation Index | 800.0 | |||
| Price Action Indicator | 425.0 | |||
| Period Momentum Indicator | 150.0 |
Daihan Pharmaceutical Forecast Models
Daihan Pharmaceutical's time-series forecasting models are one of many Daihan Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Daihan Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Daihan Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Daihan Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Daihan shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Daihan Pharmaceutical. By using and applying Daihan Stock analysis, traders can create a robust methodology for identifying Daihan entry and exit points for their positions.
,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Daihan Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |